市场调查报告书
商品编码
1467871
2024-2032 年按产品、准入、程序、最终用户和地区分類的血管闭合装置市场报告Vascular Closure Devices Market Report by Product, Access, Procedure, End-User, and Region 2024-2032 |
IMARC Group年,全球血管闭合装置市场规模达15亿美元。蓬勃发展的医疗保健产业、心血管疾病盛行率的增加以及患者对有效失血管理的需求不断增长是推动市场的一些关键因素。
血管闭合装置 (VCD) 在全球各地的医院、诊所以及专科和门诊手术中心使用,用于在血管造影后立即密封动脉中的小穿孔。与传统的机械压迫相比,这些装置广泛用于透过股骨途径接受导管插入术的患者。它们有助于降低腹股沟穿刺部位立即出血的风险。除此之外,它们还有助于建立良好的身体习惯以及抗凝血和抗血小板治疗。由于它们具有多种优势,例如缩短止血时间、促进患者活动、减轻患者因长期卧床而引起的不适、减少住院时间以及预防股动脉併发症,因此全球范围内对 VCD 的需求正在不断增加。
目前,全球中风、冠状动脉心臟病、週边动脉疾病和主动脉疾病等心血管疾病(CVD)的盛行率呈上升趋势。这与蓬勃发展的医疗保健产业一起,是支持市场成长的关键因素之一。除此之外,对诊断和治疗心血管疾病的导管插入术和介入手术的需求不断增长,为行业投资者提供了利润丰厚的成长机会。此外,医院和手术中心对先进手术设备的需求不断增长,对市场产生了积极影响。此外,世界各地在冠状动脉造影和其他介入手术期间对股骨模式血管通路的需求不断增加。再加上对避免缝合和疤痕的非侵入性手术的需求不断增长,正在对市场产生积极影响。除此之外,医生对外科手术期间患者有效失血管理的日益关注正在加强市场的成长。此外,该行业的主要製造商正专注于製造大口径血管闭合装置。与此一致的是,主要市场参与者的创新设备註册数量不断增加正在推动市场的成长。此外,大众对 VCD 好处的认识不断提高,例如微创、患者治疗效果好、早期下床活动以及手术过程中的舒适度,这些都促进了市场的成长。
The global vascular closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The burgeoning healthcare industry, increasing prevalence of cardiovascular diseases, and the rising demand for effective blood loss management in patients represent some of the key factors driving the market.
Vascular closure devices (VCDs) are used in hospitals, clinics, and specialty and ambulatory surgery centers across the globe to immediately seal the small puncture made in an artery after an angiogram. These devices are widely utilized among patients undergoing catheterization via the femoral route as compared to traditional mechanical compression. They assist in reducing the risk of immediate bleeding from the groin puncture site. Besides this, they also aid in setting a large body habitus and anticoagulation and antiplatelet therapies. As they offer various benefits, such as reducing the time to hemostasis, facilitating patient mobilization, lowering patient discomfort associated with prolonged bed rest, decreasing hospital stays, and preventing femoral artery complications, the demand for VCDs is increasing worldwide.
At present, there is a rise in the prevalence of cardiovascular diseases (CVDs), such as stroke and coronary heart, peripheral arterial, and aortic diseases, across the globe. This, along with the burgeoning healthcare industry, represents one of the key factors supporting the growth of the market. Besides this, the escalating demand for catheterization and interventional procedures for diagnosing and treating CVDs is offering lucrative growth opportunities to industry investors. In addition, the growing demand for advanced surgical equipment in hospitals and surgical centers is positively influencing the market. Moreover, there is an increase in the demand for femoral mode for vascular access during coronary angiography and other interventional procedures around the world. This, coupled with the growing demand for non-invasive procedures to avoid stitches and scarring, is positively influencing the market. Apart from this, the rising focus of doctors on effective blood loss management in patients during surgical procedures is strengthening the growth of the market. Additionally, key manufacturers operating in the industry are focusing on manufacturing large-bore vascular closure devices. In line with this, the increasing number of registrations for innovative devices by key market players is propelling the growth of the market. Furthermore, the rising awareness among the masses about the benefits of VCDs, such as enabling minimal invasions, high patient outcomes, early ambulation, and comfort during procedures, is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each segment of the global vascular closure devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, access, procedure, and end-user.
Passive Approximators
Collagen Plugs
Sealant or Gel-Based Devices
Compression-Assist Devices
Active Approximators
Suture-Based Devices
Clip-Based Devices
External Hemostatic Devices
The report has provided a detailed breakup and analysis of the vascular closure devices market based on the product. This includes passive approximators (collagen plugs, sealant or gel-based devices, and compression-assist devices), active approximators (suture-based devices and clip-based devices) and external hemostatic devices. According to the report, passive approximators represented the largest segment.
Femoral Access
Radial Access
A detailed breakup and analysis of the vascular closure devices market based on access has also been provided in the report. This includes femoral and radial access. According to the report, femoral access accounted for the largest market share.
Interventional Cardiology
Interventional Radiology/Vascular Surgery
A detailed breakup and analysis of the vascular closure devices market based on procedure has also been provided in the report. This includes the interventional cardiology and interventional radiology/vascular surgery. According to the report, interventional cardiology accounted for the largest market share.
Hospitals
Ambulatory Surgical Centers
Others
A detailed breakup and analysis of the vascular closure devices market based on end-user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for vascular closure devices. Some of factors driving the North America vascular closure devices market included the growing prevalence of cardiovascular diseases, rising trend of one-day surgeries for vascular procedures, increasing clinical trials for vascular devices, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global vascular closure devices market. Detailed profiles of all major companies have also been provided. Some of the companies include Abbott Laboratories, Cardiva Medical Inc. (Haemonetics Corporation), Cordis Corporation (Cardinal Health Inc.), ENDOCOR GmbH & Co. KG, Merit Medical Systems Inc., Morris Innovative Inc., Teleflex Incorporated, Terumo Medical Corporation (Terumo Corporation), Transluminal Technologies LLC, Vasorum Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.